Together, the existing literature as well as results from the present study suggest that it is feasible to prevent metastasis in PCA patients with localized disease through re-activating/increasing E-cadherin expression or through targeting SNAI1 expression in PCA cells by using existing or novel cancer preventive agents [68-70]. The gene discussed is SNAI1; the disease is cancer.